Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present CVR Med Corp (OTC: CRRVF).

Full DD Report for CRRVF

Recent News from (OTC: CRRVF)

CORRECTION: CVR Medical Announces Temporary Warrant Exercise Price Amendment
CVR Medical Corp. The press release that follows is re-issued due to a typographical error in the access code of the original release (issued on March 16, 2018 at 5:30 a.m. PST) whereby access code to the conference call scheduled for March 19, 2018 at 1:00 p.m. EST (10:00 a.m. PST) is a 7-di...
Source: Newsfile
Date: March, 19 2018 08:30
CVR Medical Announces Temporary Warrant Exercise Price Amendment
Vancouver, British Columbia--(Newsfile Corp. - March 16, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) (" CVR Medical ") today announced that it will temporarily reduce the exercise price of its outstanding 2017 warrants originally issued in February and April 2017 (the " ...
Source: Newsfile
Date: March, 16 2018 08:30
CVR Medical Announces Temporary Warrant Exercise Price Amendment - Company To Host Conference Call
CVR Medical Announces Temporary Warrant Exercise Price Amendment - Company To Host Conference Call
Source: OTC Markets
Date: March, 16 2018 00:00
Second Trial Data Report: Clinical Substantiation for CVR Medical
Vancouver, British Columbia--(Newsfile Corp. - March 7, 2018) - CVR Medical Corp. (TSXV: CVM ) (FSE: B3BN) (OTCQB: CRRVF) (" CVR Medical ") advisory staff member Dr. Phillip J. Bendick, PhD, has completed his second clinical report summarizing additional data collected from tertiary ...
Source: Newsfile
Date: March, 07 2018 08:30
CVR Medical Expands Clinical Footprint
Vancouver, British Columbia--(Newsfile Corp. - February 27, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) (" CVR Medical ") announces Internal Review Board (IRB) approval by The Cleveland Clinic, sanctioning CVR to conduct clinical trials using the Carotid Stenotic Scan...
Source: Newsfile
Date: February, 27 2018 08:30
Critical Milestone: CVR Medical to Launch Pivotal Trials
Vancouver, British Columbia--(Newsfile Corp. - February 20, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the launch of pivotal clinical trials beginning Monday March 5, 2018 for the Carotid Stenotic Scan (CSS) device. This anticipated milestone rep...
Source: Newsfile
Date: February, 20 2018 08:31
CVR Medical Adds Two Wireless CSS Devices to Methodist Hospital Expanding Clinical Substantiation Data for FDA Submission
Vancouver, British Columbia--(Newsfile Corp. - February 13, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces placement of two additional wireless Carotid Stenotic Scan (CSS) devices into clinical trials at historic Methodist Hospital, part of the T...
Source: Newsfile
Date: February, 13 2018 08:30
CVR Medical Adds Two Wirelss CSS Devices To Methodist Hospital - Expanding Clinical Substantiation Data for FDA Submission
CVR Medical Adds Two Wirelss CSS Devices To Methodist Hospital - Expanding Clinical Substantiation Data for FDA Submission
Source: OTC Markets
Date: February, 13 2018 00:00
CVR Medical, Canon Showcasing Carotid Stenotic Scan (CSS) at PLASTEC West 2018
Vancouver, British Columbia--(Newsfile Corp. - February 8, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) (" CVR Medical " or " CVR ") has joined Canon Virginia, Inc. (CVI) at PLASTEC West (February 6 - 8, 2018), the largest domestic conference and expo for advanced de...
Source: Newsfile
Date: February, 08 2018 08:30
CVR Medical Moving Forward With Touch Panels From Hitachi High Technologies America
Vancouver, British Columbia--(Newsfile Corp. - February 6, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) (" CVR Medical " or "CVR") announces the placement of an initial order of touch panel PC's for its "Carotid Stenotic Scan (CSS)" device. This order represents the pre...
Source: Newsfile
Date: February, 06 2018 08:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-04-200.28450.27270.28450.265687,595
2018-04-190.3050.28930.3050.2864,390
2018-04-180.3018310.290.3018310.28125,350
2018-04-170.292380.3078020.30970.2923834,794
2018-04-160.3190.29920.3190.2733104,100

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-04-2058,25087,59566.4992Short
2018-04-1946,50061,89075.1333Short
2018-04-1834,050125,35027.1639Cover
2018-04-1614,350104,10013.7848Cover
2018-04-1210,30012,70081.1024Short

* Short Mode

Short Analysis provided by Squeeze Report.


About CVR Med Corp (OTC: CRRVF)

Logo for CVR Med Corp (OTC: CRRVF)

CVR Medical is a company that is involved in an equal parts joint venture with CVR Global Inc. the Joint Venture . The Joint Venture operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic, and low frequency sound wave analysis technology and has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. CVR Medical is managed by a proven technical team.

 

Contact Information

 

 

Current Management

  • Peter Bakema / CEO, President
  • Anthony Robinson / COO
  • Erwin Wong / CFO, Other
  • Peter Bakema / Chairman
  • Benjamin Asuncion /
  • Ronnie Floyd Birch /
  • Paul Blunden /
  • Erwin Wong /

Current Share Structure

  • Market Cap: $20,961,997 - 03/20/2018
  • Issue and Outstanding: 64,938,033 - 09/28/2017

 


Recent Filings from (OTC: CRRVF)

Management Discussion and Analysis - Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate
Filing Type: Management Discussion and Analysis - Form 52-109FV2 Certification of Interim Filings Venture IssueFiling Source: OTC Markets
Filing Date: November, 29 2017
Management Discussion and Analysis - Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate
Filing Type: Management Discussion and Analysis - Form 52-109FV2 Certification of Interim Filings Venture IssuerFiling Source: OTC Markets
Filing Date: November, 29 2017
Interim Financial Report - CVR Medical Corp. Interim Financial Statements Nine Months Ended September 30, 2017
Filing Type: Interim Financial Report - CVR Medical Corp. Interim Financial Statements Nine Months Ended SeptembeFiling Source: OTC Markets
Filing Date: November, 29 2017
Management Discussion and Analysis - MANAGEMENT DISCUSSION FOR CVR MEDICAL CORP. FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2017
Filing Type: Management Discussion and Analysis - MANAGEMENT DISCUSSION FOR CVR MEDICAL CORP. FOR THE NINE MONTHSFiling Source: OTC Markets
Filing Date: November, 29 2017
Quarterly Report - Form 52-109FV2 - CFO Certification of Interim Filings
Filing Type: Quarterly Report - Form 52-109FV2 - CFO Certification of Interim FilingsFiling Source: OTC Markets
Filing Date: August, 29 2017
Quarterly Report - Form 52-109FV2 - CEO Certification of Interim Filings
Filing Type: Quarterly Report - Form 52-109FV2 - CEO Certification of Interim FilingsFiling Source: OTC Markets
Filing Date: August, 29 2017
Management Discussion and Analysis - Management Discussion for the Six Months Ended June 30, 2017
Filing Type: Management Discussion and Analysis - Management Discussion for the Six Months Ended June 30, 2017Filing Source: OTC Markets
Filing Date: August, 28 2017
Interim Financial Report - Interim Financial Statements Six Months Ended June 30, 2017
Filing Type: Interim Financial Report - Interim Financial Statements Six Months Ended June 30, 2017Filing Source: OTC Markets
Filing Date: August, 28 2017
OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: July, 05 2017
Quarterly Report - Form 52-109FV2 - CFO Certification
Filing Type: Quarterly Report - Form 52-109FV2 - CFO CertificationFiling Source: OTC Markets
Filing Date: May, 31 2017

 

 


Daily Technical Chart for (OTC: CRRVF)

Daily Technical Chart for (OTC: CRRVF)


Stay tuned for daily updates and more on (OTC: CRRVF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CRRVF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CRRVF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of CRRVF and does not buy, sell, or trade any shares of CRRVF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2016 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/

 

 

Release this Report to Investors

Via Email

Via Text

Important

If you would like to schedule the release please Contact Us and we will assist you otherwise we will release this report to investors 15 minutes after payment is received to allow the most current information to be updated before the report is sent. Interested in reaching more investors? Contact Us